Behzad Mowlazadeh
Bay Pines, FLNPI 1548207269
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,288 of the $2,104 with a category attached, or 61.2%. 33 manufacturers reported payments, led by Janssen Research & Development, LLC at 38.4% of the total. Reporting peaked in 2023 at $1,133 and has fallen 98.3% since, to $20 in 2025.
Across 55 payments — averaging $38.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$808
- Sanofi$166
- Boston Scientific$144
- Karyopharm Therapeutics Inc.$112
- Exelixis Inc.$82
- Sanofi-aventis U.S. LLC$80
- plus $713 from 27 others
Across 12 payments — averaging $2813.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$34K
What the payments were for
- Travel & lodging$65431%
- Food & beverage$1,28861%
- Education$1628%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XtandiEnzalutamide | 14 | $200,344 |
| Anastrozole | 16 | $51 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.